Infectiopôle INRS


The COVID-19 pandemic has highlighted the importance of fundamental research to prepare for a future epidemic or pandemic. With this in mind, the INRS Infectiopole brings together a unique critical mass of researchers in Quebec working to better understand the mechanisms associated with the development of infectious diseases and to develop innovative prophylactic, therapeutic, and diagnostic tools for the prevention and control of these diseases.

Infectious diseases are caused by microscopic organisms, such as bacteria, viruses, fungi, or parasites, transmitted directly or indirectly from one person to another or from an infected animal to a human. Collectively, these communicable diseases are among the leading causes of mortality and morbidity, affecting poor populations and especially children.

Although scientific advances have made it possible to better control and significantly reduce the mortality associated with infectious diseases, the increasingly frequent emergence or re-emergence of new communicable diseases illustrates their dynamic nature and the need to prepare for them. In this regard, the SARS-CoV-2 pandemic is a powerful reminder of the disruption that infectious diseases can cause to human activity.

“From a scientific perspective, the SARS-CoV-2 pandemic has clearly demonstrated the critical role of technological advances and knowledge generated by decades of research.”
— Albert Descoteaux, INRS professor

Thank you for supporting the INRS Infectiopole, the Institut national de la recherche scientifique’s center of excellence for research and training on infectious diseases.

Support the vital work of our scientists today! 

Thank you.


INRS faculty and staff: you may make a donation through payroll deductions. 


The INRS Foundation, which is supporting Institut national de la recherche scientifique (INRS), is a charity registered in Canada under the number 725310676RR0001. Upon donating online, here is the merchant name that will appear on your credit card statement: BAM*DON FINRS.